These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28027027)

  • 41. Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment.
    Bromberg DJ; Galvez de Leon SJ; Litz T; Azbel L; Liberman AR; Polonsky M; Dvoriak S; Saichuk N; Taxman F; Altice FL
    PLOS Glob Public Health; 2023; 3(11):e0002349. PubMed ID: 37910486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
    Jarvis BP; Holtyn AF; Berry MS; Subramaniam S; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    J Subst Abuse Treat; 2018 Feb; 85():38-44. PubMed ID: 28449955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015.
    Mantha S; Mauro PM; Mauro CM; Martins SS
    Drug Alcohol Depend; 2020 Jan; 206():107654. PubMed ID: 31735533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose.
    Guarino H; Mateu-Gelabert P; Teubl J; Goodbody E
    Addict Behav; 2018 Nov; 86():118-123. PubMed ID: 29747875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PROTOCOL: Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
    Strange CC; Manchak SM; Hyatt JM; Haberman C; Desai A
    Campbell Syst Rev; 2021 Mar; 17(1):e1138. PubMed ID: 37050968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender differences in mortality among treated opioid dependent patients.
    Evans E; Kelleghan A; Li L; Min J; Huang D; Urada D; Hser YI; Nosyk B
    Drug Alcohol Depend; 2015 Oct; 155():228-35. PubMed ID: 26282107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.
    Evans E; Li L; Min J; Huang D; Urada D; Liu L; Hser YI; Nosyk B
    Addiction; 2015 Jun; 110(6):996-1005. PubMed ID: 25644938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initiation into prescription opioid misuse amongst young injection drug users.
    Lankenau SE; Teti M; Silva K; Jackson Bloom J; Harocopos A; Treese M
    Int J Drug Policy; 2012 Jan; 23(1):37-44. PubMed ID: 21689917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia.
    Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Bonn M; Wheeler A; Grebely J; Farrell M; Hickman M; Hayward A; Degenhardt L
    Int J Drug Policy; 2023 Dec; 122():104218. PubMed ID: 37813083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
    Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
    Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
    Manhapra A; Stefanovics E; Rosenheck R
    Subst Abus; 2020; 41(1):110-120. PubMed ID: 31403914
    [No Abstract]   [Full Text] [Related]  

  • 53. The dynamics of heroin and illicit opioid use disorder, casual use, treatment, and recovery: A mathematical modeling analysis.
    Cole S; Olive MF; Wirkus S
    Math Biosci Eng; 2024 Feb; 21(2):3165-3206. PubMed ID: 38454724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.
    Dickson-Gomez J; Krechel S; Spector A; Weeks M; Ohlrich J; Green Montaque HD; Li J
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):55. PubMed ID: 35864522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From oxycodone to heroin: two cases of transitioning opioid use in young Australians.
    Dertadian GC; Maher L
    Drug Alcohol Rev; 2014 Jan; 33(1):102-4. PubMed ID: 24256365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling the Dynamics of Heroin and Illicit Opioid Use Disorder, Treatment, and Recovery.
    Cole S; Wirkus S
    Bull Math Biol; 2022 Mar; 84(4):48. PubMed ID: 35237877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in opioid initiation among people who use opioids in three US cities.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Drug Alcohol Rev; 2020 May; 39(4):375-383. PubMed ID: 32249463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
    Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; MacDonald R; Lee JD
    Addiction; 2023 Mar; 118(3):459-467. PubMed ID: 36305669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.
    Krawczyk N; Feder KA; Fingerhood MI; Saloner B
    Drug Alcohol Depend; 2017 Sep; 178():512-518. PubMed ID: 28719885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
    J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.